Semaglutide for MASH in Japanese patients: findings consistent with the overall ESSENCE population - Quiz - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

Semaglutide outcomes in Japanese patients with MASH align with results from the overall ESSENCE trial population

  • By

  • Hayato Nakagawa

  • October 27, 2026

Share

Original Source(s)

Semaglutide for MASH in Japanese patients: findings consistent with the overall ESSENCE population

  • by Hayato Nakagawa

  • October 27, 2026

Related Content

“A long bristling road full of adventure, full of discovery” gene therapy approaches in transfusion-dependent thalassemia: The EHA-EBMT consensus paper

Computer vision augmented indocyanine green near-infrared fluorescence (ICG-NIRF) signal-to-background ratio (SBR) for identification of extrahepatic biliary structures in laparoscopic cholecystectomy

Author Correction: Liquid biopsy for early detection of pancreatic ductal adenocarcinoma